Petros Pharmaceuticals Inc (PTPI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 2,250 | 3,173 | -2,260 | -14,319 | -5,045 |
| Depreciation Amortization | N/A | N/A | N/A | 5,911 | N/A |
| Accounts receivable | N/A | N/A | N/A | 1,819 | N/A |
| Accounts payable and accrued liabilities | -343 | 206 | -212 | 616 | -68 |
| Other Working Capital | 7 | 292 | -164 | 4,527 | -429 |
| Other Operating Activity | -7,715 | -8,338 | 976 | -1,156 | 1,974 |
| Operating Cash Flow | $-5,801 | $-4,667 | $-1,660 | $-2,603 | $-3,569 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | -25 | -19 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $-25 | $-19 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | -765 | N/A |
| Common Stock Issued | 8,503 | 8,503 | 8,707 | N/A | N/A |
| Other Financing Activity | -342 | -224 | 0 | -6,234 | -5,855 |
| Financing Cash Flow | $8,162 | $8,279 | $8,707 | $-6,999 | $-5,855 |
| Beginning Cash Position | 3,710 | 3,710 | 3,710 | 13,337 | 13,337 |
| End Cash Position | 6,070 | 7,322 | 10,757 | 3,710 | 3,895 |
| Net Cash Flow | $2,360 | $3,612 | $7,047 | $-9,627 | $-9,442 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,801 | -4,667 | -1,660 | -2,603 | -3,569 |
| Capital Expenditure | N/A | N/A | N/A | -25 | -19 |
| Free Cash Flow | -5,801 | -4,667 | -1,660 | -2,628 | -3,588 |